Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • Germintec

    Uploaded by

    Koesheryanto
    67 views3 pages
    The GRED Group invested €4 million in Germitec to accelerate the rollout of its new disinfection method, Antigermix, for medical instruments like ultrasound probes. Antigermix uses UV light for high-level disinfection in 90 seconds, providing a simple, non-toxic alternative to traditional hydrogen peroxide methods. The funding will allow Germitec to expand in Europe and apply for FDA approval in the US to address increased demand and regulations for safer ultrasound probe disinfection.

    Original Description:

    Sterilizer uv c

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The GRED Group invested €4 million in Germitec to accelerate the rollout of its new disinfection method, Antigermix, for medical instruments like ultrasound probes. Antigermix uses UV light for high-level disinfection in 90 seconds, providing a simple, non-toxic alternative to traditional hydrogen peroxide methods. The funding will allow Germitec to expand in Europe and apply for FDA approval in the US to address increased demand and regulations for safer ultrasound probe disinfection.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    67 views3 pages

    Germintec

    Uploaded by

    Koesheryanto
    The GRED Group invested €4 million in Germitec to accelerate the rollout of its new disinfection method, Antigermix, for medical instruments like ultrasound probes. Antigermix uses UV light for high-level disinfection in 90 seconds, providing a simple, non-toxic alternative to traditional hydrogen peroxide methods. The funding will allow Germitec to expand in Europe and apply for FDA approval in the US to address increased demand and regulations for safer ultrasound probe disinfection.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 3

    GRED Group invests €4 million in Germitec

    GRED announces support for Germitec who will use the funds to
    accelerate rollout of Antigermix, a new disinfection method for medical
    instruments, compliant with the latest requirements for ultrasound
    probes

    Ivry-sur-Seine, near Paris, France, July 10, 2018 — The GRED Group announces that
    it has provided financial support for Germitec, a company that develops and sells
    innovative disinfection systems for hospital hygiene. This €4M financing enables Germitec
    to meet the demand in the healthcare sector for a simple solution to ensure compliance
    with the new requirements in ultrasound probe disinfection. Thanks to this investment,
    Germitec will be able to expand its presence in the European market and apply for FDA
    approval in the United States.

    The new global standards introducing requirements for disinfecting ultrasound probes and
    Germitec’s proven disinfection chamber technology convinced the GRED group to provide
    new financing for the company. With the new funds, Germitec aims to become the leader
    in the disinfection market, estimated at around €1 billion in high-income countries.

    According to current guidelines, endo-cavity and transesophageal (TO) ultrasound probes


    must be disinfected between each use. In 2017, new requirements from the World
    Federation for Ultrasound in Medicine and Biology (WFUMB1), the European Federation of
    Societies for Ultrasound in Medicine and Biology (EFSUMB2) and the European Society of
    Radiology (ESR3) highlighted the need for High Level Disinfection (HLD). The traditional
    HLD techniques such as chemical soaking, the use of multiple wipes or semi-automated
    systems use hydrogen peroxide (H2O2), a toxic chemical product, are complex and take
    between 10 and 30 minutes4. Alternative solutions are therefore demanded, especially in
    the United States5.

    Germitec offers an innovative approach by using UV disinfection thus creating the first
    photonic high-level disinfection (HLD) system. The company’s products, Antigermix AS1
    for vaginal and rectal probes and Antigermix AE1 for TO probes, are high speed (≈90
    seconds), easy to use and pose no toxic risk (neither fumes nor residues left on the
    instruments). In contrast to other HLD techniques, these products do not require any
    consumables, the probe does not need to be removed from the system at the end of
    disinfection process and it does not require rinsing. The system uses sensors to check that
    the disinfection has been successful, in contrast to chemical systems which are operator-
    dependent. It uses a single plug socket and offers automatic traceability using RFID probe
    identification. There is no longer the need to manually update the traceability log book to
    ensure compliance for healthcare centers using such devices. Lastly, photonic disinfection

    1 “Guidelines for Cleaning Transvaginal Ultrasound Transducers Between Patients”, https://www.ncbi.nlm.nih.gov/pubmed/28190623


    2 “Best Practice recommendations for cleaning and disinfection of ultrasound transducers whilst maintaining transducer integrity”,
    http://www.efsumb.org/safety/resources/2017-probe_cleaning.pdf
    3 “Infection prevention and control in ultrasound - best practice recommendations from the European Society of Radiology Ultrasound
    Working Group”, https://link.springer.com/article/10.1007/s13244-017-0580-3
    4 “Evaluation of a hydrogen peroxide-based system for high-level disinfection of vaginal ultrasound probes”,
    https://www.ncbi.nlm.nih.gov/pubmed/24065261
    5 “Emergency department ultrasound probe infection control: challenges and solutions”,
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806800/
    has been shown to be effective against HPV6, which is a specific problem for endo-cavity
    ultrasound probes.

    This automatic HLD photonic platform has increasingly been recognized by international
    authorities and societies, which consider it as an appropriate method for disinfecting
    ultrasound probes. These include the FNMR (French National Federation of Radiologists),
    WFUMB, ESR, EFSUMB and DEGUM (German Society for Ultrasound in Medicine). A number
    of authorities have also indicated that this new disinfection method shows a higher level
    of scientific evidence than others (NHS Scotland7) and is a true innovation (Rapid Review
    Panel, NHS UK8).

    Used as a routine method, Antigermix achieves substantial savings for users by allowing
    them to increase by five-fold the number of examinations performed (Urology Department
    at the HEGP in Paris) or reduce the number of required probes to a fifth (IVF Department
    at Saint Joseph Marseille). Healthcare professionals can even substantially reduce the rate
    of probe breakage (Créteil Hospital).

    See the video here:


    https://www.youtube.com/watch?v=YbHZtMKICvY&feature=youtu.be

    “We are very enthusiastic as this new investment will enable us to distribute our technology
    more widely. In Europe, we will create sales networks in the UK and Germany. In the US,
    where we receive many inquiries, we plan to start sales in early 2019. Germitec aims to
    provide a simple solution for sonographers now faced with more stringent disinfection
    requirements. Since the beginning of the year, we have sold four times as many systems
    as in the same period in 2017,” said Clément Deshays, founder and CEO of Germitec. “Our
    solution radically simplifies the lives of healthcare professionals. It gives them peace of
    mind so they can concentrate on their patients, without worrying about toxic chemical
    products, manual traceability or disinfection time. Antigermix works more quickly than the
    time it takes to bring the next patient in, which maximizes the number of examinations
    that can be performed daily without necessitating the purchase of additional probes. We
    are most grateful to our shareholders and users who, through their commitment, are
    creating a new standard in ultrasound practice.”

    “Since its creation, the GRED group has worked closely with radiologists and healthcare
    facilities. We quickly identified the issues posed by the disinfection of ultrasound probes in
    terms of toxicity, financial cost and planning management,” said René Deshays, founder
    and president of the GRED group. “We are very proud to continue to support Germitec’s
    growth by offering a unique, high-speed and non-chemical solution that integrates
    seamlessly into the regular workflow. GRED has always worked to serve the healthcare
    sector and we are aware of the issues faced by ultrasound professionals who have a very
    heavy workload and have (in many countries) very little recognition for their work. Along
    with Germitec, we are happy to provide them with a perfectly tailored solution in terms of
    organization and economic performance.”

    Financial advisor: Comauditex -Legal advisor: M. Immelé

    About GRED
    René Deshays created and leads the Groupe René Eric Deshays (GRED), a major

    6 “UVC radiation as an effective disinfectant method to inactivate human papillomaviruses”,


    http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187377
    7
    “Guidance for Decontamination of Semi-Critical Ultrasound Probes”,
    http://www.hps.scot.nhs.uk/haiic/decontamination/resourcedetail.aspx?id=1703
    8
    “1502-02: Germitec – Antigermix AS1 Evaluated by the Rapid Review Panel”,
    https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/410002/1502-
    02_Germitec_Antigermix_S1.pdf
    stakeholder in the health sector in France, creating companies that become champions in
    their market segments. Notably, GRED is responsible for the distribution and servicing of
    Fujifilm radiology devices in France through the companies FMSF and TSR, that were sold
    to Fuji Photo Film in 2005. GRED also created and developed Softway Medical.

    About Germitec
    Created in 2005 and based in Ivry, near Paris, France, Germitec has 14 staff. It developed
    the first photonic ILD-HLD platform, Antigermix, which it intends to offer for a range of
    medical instruments such as ultrasound probes. The company is ISO 13485 certified.
    Germitec is an innovative company according to French investment bank BPI. A PM’UP
    prize winner, it was awarded the European Commission’s Certificate of Excellence as part
    of the Horizon 2020 projects. In 2017, the company generated sales of around €1.5 million
    ($1.75M).
    https://www.germitec.com/en/

    Press and Analyst Contacts


    Andrew Lloyd & Associates
    Agnes Stephens — Kübra Somuncu
    agnes@ala.com - kubra@ala.com
    Tel: +44 1273 675 100
    @ALA_Group

    You might also like